# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA1660231 | Functional | Antimicrobial activity against Trypanosoma evansi STIB 806K infected in NMRI mouse assessed as host survival days at 0.5 mg/kg, ip administered 3 to 6 days after infection for 4 consecutive days | Trypanosoma evansi | 21 | ALA1649292 | organism-based format | Scientific Literature | |
2. | ALA1660236 | Functional | Antimicrobial activity against Trypanosoma evansi STIB 806K infected in NMRI mouse assessed as complete cure from microbial infection at 0.5 mg/kg, ip administered 3 to 6 days after infection for 4 consecutive days | Trypanosoma evansi | 14 | ALA1649292 | organism-based format | Scientific Literature | |
3. | ALA4814082 | ADME | Drug localization in nucleus of human HT-29 cells at 5 uM incubated for 16 hrs by DiOC6/propidium iodide staining based by fluorescence microscopy | Homo sapiens | 7 | ALA4813909 | subcellular format | Scientific Literature | |
4. | ALA4814083 | Binding | Inhibition of HOXA9 (unknown origin) expressed in reticulocyte lysate system binding to DNA Hoxa9-binding site (5'-biotin-cctctcctctcctGCGATGATTTACGACCGC) (unknown origin) assessed as Hoxa9/DNA remaining complexes at 5 to 10 uM incubated for 20 mins with DNA followed by compound wash out and subsequent HOXA9 addition and measured after 1 hr by ELISA | 39 | ALA4813909 | subcellular format | Scientific Literature |